TrialArthritis research & therapy2014

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.

Peter E Lipsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.